Navigation Links
Fragile X and Down syndromes share signalling pathway for intellectual disability
Date:8/3/2012

HEIDELBERG, 3 August 2012 Intellectual disability due to Fragile X and Down syndromes involves similar molecular pathways report researchers in The EMBO Journal. The two disorders share disturbances in the molecular events that regulate the way nerve cells develop dendritic spines, the small extensions found on the surface of nerve cells that are crucial for communication in the brain.

"We have shown for the first time that some of the proteins altered in Fragile X and Down syndromes are common molecular triggers of intellectual disability in both disorders," said Kyung-Tai Min, one of the lead authors of the study and a professor at Indiana University and the Ulsan National Institute of Science and Technology in Korea. "Specifically, two proteins interact with each other in a way that limits the formation of spines or protrusions on the surface of dendrites." He added: "These outgrowths of the cell are essential for the formation of new contacts with other nerve cells and for the successful transmission of nerve signals. When the spines are impaired, information transfer is impeded and mental retardation takes hold."

Intellectual disability is a developmental brain disorder that leads to impaired cognitive performance and mental retardation. Two of the most prevalent genetic causes of intellectual disability in humans are Fragile X and Down syndromes. Fragile X syndrome arises from a single gene mutation that prevents the synthesis of a protein required for neural development (Fragile X mental retardation protein). The presence of all or a part of a third copy of chromosome 21 in cells causes Down syndrome. Although both syndromes arise due to these fundamental genetic differences, the researchers identified a shared molecular pathway in mice that leads to intellectual disability for both disorders.

The mice that were used in the experiments are model systems for the study of Fragile X syndrome and Down syndrome. Down syndrome mice have difficulties with memory and brain function, and the formation of the heart is often compromised, symptoms that are also observed in humans with Down syndrome. Both model systems are very useful to scientists looking to dissect the molecular events that occur as the disorders take hold.

The scientists revealed that the Down syndrome critical region 1 protein (DSCR1) interacts with Fragile X mental retardation protein (FMRP) to regulate dendritic spine formation and local protein synthesis. By using specific antibodies that bind to the proteins as well as fluorescent labeling techniques they showed that DSCR1 specifically interacts with the phosphorylated form of FMRP. The overlapping molecular pathways of intellectual disability in both genetic disorders suggest that a common therapeutic approach might be feasible for both syndromes.

Min remarked: "We believe these experiments provide an important step forward in understanding the multiple roles of DSCR1 in neurons and in identifying a molecular interaction that is closely linked to intellectual disability for both syndromes."

DSCR1 interacts with FMRP and is required for spine morphogenesis and local protein synthesis


'/>"/>
Contact: Barry Whyte
barry.whyte@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert  

Related biology news :

1. Stem cell research paves way for progress on dealing with Fragile X retardation
2. Stanford scientists document fragile land-sea ecological chain
3. A new pipewort species from a unique, but fragile habitat in India
4. Myelodysplastic syndromes (MDS) linked to abnormal stem cells
5. F1000 Research partners with figshare to provide smart ways of accessing data
6. Investigation of American Oriental Bioengineering, Inc. by Securities Lawyers at Goldfarb LLP Law Firm for Potential Shareholder Claim
7. Gut microbes battle a common set of viruses shared by global populations
8. UCSB researchers to examine the effects of year-old NOAA West Coast Catch Shares program
9. Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
10. Study identifies pathway to enhance usefulness of EGFR inhibitors in lung cancer treatment
11. A new candidate pathway for treating visceral obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fragile X and Down syndromes share signalling pathway for intellectual disability
(Date:1/23/2017)... , Jan. 23, 2017  The latest mobile market ... prices have dropped dramatically. The quarterly average price of ... to $276 in Q4 2016.  There are now 120 ... of $116, up from just 28 a year ago ... According to Maxine Most , Acuity Market Intelligence ...
(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
(Date:1/12/2017)... Jan. 12, 2017  New research undertaken by Fit ... the future.  1,000 participants were simply asked which office technology ... we may consider standard issue.  Insights on what will ... also gathered from futurists and industry leaders including Penelope ... Canton .  Some of these findings ...
Breaking Biology News(10 mins):
(Date:2/15/2017)... Feb. 15, 2017  NASA provider SpaceX is scheduled ... the  International Space Station  no earlier than 10:01 a.m. ... will begin at 8:30 a.m. on NASA Television and ... spacecraft will lift off on the company,s Falcon ... Kennedy Space Center in ...
(Date:2/15/2017)... WARRINGTON, Pa. , Feb. 15, 2017 /PRNewswire/ ... ), a biotechnology company focused on developing aerosolized ... that it has completed a $10.5 million private ... expects that it has sufficient capital to fund ... 2b clinical trial data release in mid-2017. ...
(Date:2/15/2017)... ... February 15, 2017 , ... Morris ... sixth annual open house and technology show, Morris Madness, March 14-15, 2017 in ... demos from Okuma, Tsugami and Hardinge Group in addition to displays of tooling, ...
(Date:2/15/2017)... SOUTH SAN FRANCISCO, Calif. , Feb. 15, 2017 ... on discovering and developing drugs that promote the repair ... million Series A financing led by The Column Group, ... San Francisco . The funds will be used ... unlocking the therapeutic potential of Wnt signaling, which plays ...
Breaking Biology Technology: